{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:24:32Z","timestamp":1793053472122,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Biotechnology, Government of India, Ramalingaswami Fellowship","award":["BT\/RLF\/Re-entry\/21\/2018"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/21\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    High risk Human papillomavirus (hrHPV) is a leading cause of cervical cancer. Numerous studies have demonstrated the utility of plasma HPV circulating tumor DNA (ctDNA) for disease monitoring in cervical cancer, nevertheless with diverse accuracies. We investigated whether higher sample and reaction volumes using nanoplate based digital PCR (dPCR) system offered enhanced sensitivity and reproducibility, crucial for detecting low-copies of HPV ctDNA. A multiplex dPCR assay was optimized for detecting hrHPV16, 18, and 31 plasma ctDNA from pre-treatment and follow-up plasma samples of 87 cervical cancer patients using Qiagen QIAcuity One dPCR. The assay demonstrated 98% sensitivity and 100% specificity for detecting HPV ctDNA from pre-treatment plasma cell-free DNA (cfDNA). Persistence of HPV ctDNA during follow up associated with disease relapse, while clearance of HPV ctDNA was observed in patients without recurrence. Higher sample and dPCR reaction volumes increased the sensitivity of the test, while HPV ctDNA monitoring effectively reflected disease burden.\n                    <jats:bold>Trial registration:<\/jats:bold>\n                    Clinical Trials Registry of India (CTRI\/2020\/01\/022862); registered on 20 January 2020.\n                  <\/jats:p>","DOI":"10.1038\/s41698-026-01424-y","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:18:24Z","timestamp":1776752304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nanoplate based digital PCR assay for effective quantification of plasma HPV circulating tumor DNA"],"prefix":"10.1038","volume":"10","author":[{"given":"Preetiparna","family":"Parida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Baburaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay A.","family":"Shettigar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Sharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehta Vedant","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"P V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"N. P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena A. N.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamee","family":"Shastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadev","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5306-1649","authenticated-orcid":false,"given":"Shirley","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-0097","authenticated-orcid":false,"given":"Rama Rao","family":"Damerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"1424_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1424_CR2","unstructured":"Cervical cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"key":"1424_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","volume":"22","author":"Z Petersen","year":"2022","unstructured":"Petersen, Z. et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Women\u2019s. Health 22, 486 (2022).","journal-title":"BMC Women\u2019s. Health"},{"key":"1424_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3802\/jgo.2012.23.4.282","volume":"23","author":"JD Boone","year":"2012","unstructured":"Boone, J. D., Erickson, B. K. & Huh, W. K. New insights into cervical cancer screening. J. Gynecol. Oncol. 23, 282\u2013287 (2012).","journal-title":"J. Gynecol. Oncol."},{"key":"1424_CR5","doi-asserted-by":"crossref","unstructured":"Rosing, F. et al. Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR. Microbiol. Spectr. 12, e00024 (2024).","DOI":"10.1128\/spectrum.00024-24"},{"key":"1424_CR6","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-21-0625","volume":"27","author":"E Jeannot","year":"2021","unstructured":"Jeannot, E. et al. Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer. Clin. Cancer Res. 27, 5869\u20135877 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1424_CR7","doi-asserted-by":"publisher","unstructured":"Han, K. et al. Circulating human papillomavirus DNA as a biomarker of response in patients with locally advanced cervical cancer treated with definitive chemoradiation. JCO Precision Oncol. 1\u20138 https:\/\/doi.org\/10.1200\/PO.18.00152 (2018).","DOI":"10.1200\/PO.18.00152"},{"key":"1424_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100154","volume":"6","author":"L Cabel","year":"2021","unstructured":"Cabel, L. et al. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer. ESMO Open 6, 100154 (2021).","journal-title":"ESMO Open"},{"key":"1424_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2023.100133","volume":"3","author":"C Scimone","year":"2024","unstructured":"Scimone, C. et al. Technical evaluation of a novel digital PCR platform for detecting EGFR\/KRAS mutations in NSCLC archived plasma specimens. J. Liq. Biopsy 3, 100133 (2024).","journal-title":"J. Liq. Biopsy"},{"key":"1424_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ygyno.2022.07.028","volume":"167","author":"L Sivars","year":"2022","unstructured":"Sivars, L. et al. Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer. Gynecol. Oncol. 167, 107\u2013114 (2022).","journal-title":"Gynecol. Oncol."},{"key":"1424_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/JCO.23.00954","volume":"42","author":"K Han","year":"2024","unstructured":"Han, K. et al. Clinical validation of human papilloma virus circulating tumor DNA for early detection of residual disease after chemoradiation in cervical cancer. JCO 42, 431\u2013440 (2024).","journal-title":"JCO"},{"key":"1424_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cjp2.47","volume":"2","author":"E Jeannot","year":"2016","unstructured":"Jeannot, E. et al. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma. J. Pathol. Clin. Res. 2, 201\u2013209 (2016).","journal-title":"J. Pathol. Clin. Res."},{"key":"1424_CR13","doi-asserted-by":"publisher","first-page":"e00446","DOI":"10.1016\/j.plabm.2024.e00446","volume":"43","author":"S Pandey","year":"2024","unstructured":"Pandey, S. & Yadav, P. Liquid biopsy in cancer management: Integrating diagnostics and clinical applications. Pract. Lab. Med. 43, e00446 (2024).","journal-title":"Pract. Lab. Med."},{"key":"1424_CR14","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/s41416-023-02233-x","volume":"128","author":"S Mittelstadt","year":"2023","unstructured":"Mittelstadt, S. et al. Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse. Br. J. Cancer 128, 2097 (2023).","journal-title":"Br. J. Cancer"},{"key":"1424_CR15","first-page":"3","volume":"11","author":"SM Dong","year":"2002","unstructured":"Dong, S. M. et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma1. Cancer Epidemiol. Biomark. Prev. 11, 3\u20136 (2002).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1424_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/ijgc-00009577-200409000-00025","volume":"14","author":"HJ Yang","year":"2004","unstructured":"Yang, H. J. et al. Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int. J. Gynecol. Cancer 14, 903\u2013910 (2004).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"1424_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jjco\/hyp193","volume":"40","author":"T Shimada","year":"2010","unstructured":"Shimada, T. et al. Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer. Jpn. J. Clin. Oncol. 40, 420\u2013424 (2010).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"1424_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcv.2019.03.005","volume":"114","author":"TH Cheung","year":"2019","unstructured":"Cheung, T. H. et al. Liquid biopsy of HPV DNA in cervical cancer. J. Clin. Virol. 114, 32\u201336 (2019).","journal-title":"J. Clin. Virol."},{"key":"1424_CR19","unstructured":"Digital PCR | Nanoplate dPCR technology | QIAGEN. http:\/\/www.qiagen.com\/us\/applications\/digital-pcr."},{"key":"1424_CR20","doi-asserted-by":"crossref","unstructured":"B\u00f8nl\u00f8kke, S. et al. The diagnostic value of circulating cell-free HPV DNA in plasma from cervical cancer patients. Cells 11, 2170 (2022).","DOI":"10.3390\/cells11142170"},{"key":"1424_CR21","first-page":"PO.18.00276","volume":"3","author":"RR Damerla","year":"2019","unstructured":"Damerla, R. R. et al. Detection of early human papillomavirus\u2013associated cancers by liquid biopsy. JCO Precis Oncol. 3, PO.18.00276 (2019).","journal-title":"JCO Precis Oncol."},{"key":"1424_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ejso.2007.01.014","volume":"33","author":"DC Damin","year":"2007","unstructured":"Damin, D. C. et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur. J. Surg. Oncol. 33, 569\u2013574 (2007).","journal-title":"Eur. J. Surg. Oncol."},{"key":"1424_CR23","doi-asserted-by":"publisher","first-page":"e0142572","DOI":"10.1371\/journal.pone.0142572","volume":"10","author":"I Svobodov\u00e1","year":"2015","unstructured":"Svobodov\u00e1, I. et al. Performance of droplet digital PCR in non-invasive fetal RHD genotyping - comparison with a routine real-time PCR based approach. PLoS ONE 10, e0142572 (2015).","journal-title":"PLoS ONE"},{"key":"1424_CR24","first-page":"S49","volume":"29","author":"DA Armbruster","year":"2008","unstructured":"Armbruster, D. A. & Pry, T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem Rev. 29, S49\u2013S52 (2008).","journal-title":"Clin. Biochem Rev."},{"key":"1424_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40291-024-00743-9","volume":"28","author":"A Qvick","year":"2024","unstructured":"Qvick, A. et al. Sensitive and specific droplet digital PCR assays for circulating tumor HPV DNA: development, validation, and clinical application in HPV-associated cancers. Mol. Diagn. Ther. 28, 835\u2013845 (2024).","journal-title":"Mol. Diagn. Ther."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01424-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01424-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01424-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:45:57Z","timestamp":1782081957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01424-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01424-y","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}